LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

9.4 -1.47

Résumé

Variation du prix de l'action

24h

Actuel

Min

9.1

Max

9.87

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+17.8% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-181M

735M

Ouverture précédente

10.87

Clôture précédente

9.4

Sentiment de l'Actualité

By Acuity

100%

0%

333 / 349 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 mars 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 mars 2026, 23:36 UTC

Market Talk
Principaux Événements d'Actualité

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 mars 2026, 23:35 UTC

Acquisitions, Fusions, Rachats

Pernod Ricard: Confirms Discussions With Brown-Forman

26 mars 2026, 23:29 UTC

Résultats

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 mars 2026, 23:28 UTC

Résultats

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 mars 2026, 23:28 UTC

Résultats

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 mars 2026, 23:28 UTC

Résultats

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 mars 2026, 23:27 UTC

Résultats

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 mars 2026, 23:27 UTC

Résultats

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 mars 2026, 23:08 UTC

Market Talk

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 mars 2026, 23:04 UTC

Acquisitions, Fusions, Rachats

Pernod in Deal Talks With Brown-Forman -- WSJ

26 mars 2026, 22:41 UTC

Acquisitions, Fusions, Rachats

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 mars 2026, 22:41 UTC

Acquisitions, Fusions, Rachats

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 mars 2026, 22:26 UTC

Résultats

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 mars 2026, 22:26 UTC

Résultats

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 mars 2026, 22:26 UTC

Résultats

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 mars 2026, 22:08 UTC

Résultats

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 mars 2026, 22:08 UTC

Résultats

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 mars 2026, 22:08 UTC

Résultats

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 mars 2026, 22:07 UTC

Market Talk
Principaux Événements d'Actualité

Global Energy Roundup: Market Talk

26 mars 2026, 22:07 UTC

Market Talk
Principaux Événements d'Actualité

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 mars 2026, 22:00 UTC

Résultats

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 mars 2026, 22:00 UTC

Résultats

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 mars 2026, 22:00 UTC

Résultats

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 mars 2026, 21:38 UTC

Acquisitions, Fusions, Rachats

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

17.8% hausse

Prévisions sur 12 Mois

Moyen 11.25 USD  17.8%

Haut 13 USD

Bas 9 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

5 ratings

0

Achat

3

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

333 / 349Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat